Sarepta Therapeutics

Nvidia, Meta, Sarepta, D-Wave, And Tesla: Why These 5 Stocks Are On Investors' Radars Today

Notable Insider Buys In The Past Week: General Electric, Symantec And More

Barron's On: Pharma's Big Hope

Notable Insider Buys In The Past Week: General Electric, Symantec And More

Barron's On: Pharma's Big Hope

Sarepta Therapeutics Volatile After Traders React To Exondys 51 Adverse Events

Barron's Picks And Pans: Bank Stocks, O'Reilly Automotive, Sarepta And More

Sarepta Therapeutics Volatile After Traders React To Exondys 51 Adverse Events

|

Barron's Picks And Pans: Bank Stocks, O'Reilly Automotive, Sarepta And More

|

2 Opposing Views On The Future Of Sarepta

|

Patent Trial And Appeal Board Hands Sarepta Another Big Win

|

Sarepta Therapeutics Recent News

Sarepta Prices Newly-Approved DMD Drug, Cowen Upgrades Stock To Outperform

|

Why Did Sarepta Therapeutics Plunge 20%?

|

Sarepta Therapeutics Surges 20% On No News

|

The Street's Feuerstein Breaks Down Sarepta's 40% Plunge

|

Barron's Picks And Pans: Ford, Intel, Sealed Air And More

|

Sarepta Therapeutics Dropped 10% Following FDA News

|

Forbes: There Is 'A Bit' Of Hope For Sarepta Therapeutics

|

Barron's Recap: 16 All-Star Women Financial Advisors

|

Markets Continue To Rally As The Dow Closes Above 17,000

|

Markets Virtually Flat, Oil Continues To Decline Following Bearish Outlook

|

Stocks Mixed Despite Better Than Expected GDP

|

Stocks Close Lower On Economic Concerns In Europe

|

Market Wrap For May 22: Markets Barely Positive

|

Market Wrap For April 22: S&P Rises For Sixth Straight Day, Dow & Nasdaq Also Positive

|

Market Wrap For January 6: Busy Day For Analysts Upgrades and Downgrades

|

Barron's Recap (3/23/13): World's Best CEOs

|

BioMarin, Prestige Brands and Other Top Performing Health Care Stocks in November

|

Barron's Recap (8/25/12): Best and Worst Run States

|